Trademark: 74545050
Word
LOTUS LOTUS BIOCHEMICAL CORPORATION
Status Date
Saturday, October 25, 2003
Registration Number
2031398
Registration Date
Tuesday, January 21, 1997
Filing Date
Thursday, June 30, 1994
Published for Opposition
Tuesday, May 7, 1996
Cancellation Date
Saturday, October 25, 2003
5 pharmaceutical preparations for - (1) the treatment of psychoneurotic patients with depression and/or anxiety; depression and/or anxiety associated with alcoholism; depression and/or anxiety associated with organic disease; psychotic depressive disorders associated with anxiety including involutional depression and manic-depressive disorders; (2) therapy to abort or prevent vascular headache, e.g., migraine, migraine variants, or so called "histaminic cephalalgia"; (3) the management of exogenous obesity as a short-term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction; (4) the treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible; (5) the treatment of moderate to severe vasomotor symptoms associated with the menopause; atrophic vaginitis; kraurosis vulvae; female hypogonadism; female castration; primary ovarian failure; breast cancer (for palliation only) in appropriately selected women and men with metastatic disease; prostatic carcinoma-palliative therapy of advanced disease
"BIOCHEMICAL CORPORATION"
LOTUS LOTUS BIOCHEMICAL CORPORATION
Oct 26, 2004
Paper Received
Oct 25, 2003
Cancelled Sec. 8 (6-Yr)
Jan 21, 1997
Registered-Principal Register
May 7, 1996
Published For Opposition
Apr 5, 1996
Notice Of Publication
Feb 27, 1996
Approved For Pub - Principal Register
Dec 1, 1995
Correspondence Received In Law Office
Jun 1, 1995
Final Refusal Mailed
Feb 13, 1995
Correspondence Received In Law Office
Dec 13, 1994
Non-Final Action Mailed
Dec 6, 1994
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
